TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CVKD

Cadrenal Therapeutics, Inc.

Healthcare · Biotechnology

1.10$ +3.7% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Cadrenal Therapeutics, Inc. (CVKD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 88.1% of the shares are freely tradable; institutional investors hold 6.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 6.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 16.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 88.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 3Mio.

Largest Shareholders

Institutions

Institutions CVKD
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 1.27 45,201 +0.0 03/31/2026
Geode Capital Management, LLC 0.61 21,626 +48.9 03/31/2026
Vanguard Fiduciary Trust Co 0.23 8,311 +0.0 03/31/2026
JPMorgan Chase & Co 0.21 7,500 +0.0 03/31/2026
BlackRock Inc 0.15 5,496 +56.0 03/31/2026

Funds

Funds CVKD
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 0.93 33,278 +0.0 07/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.47 16,859 +0.0 07/31/2026
Abante Quant Value FI 0.36 12,949 +0.0 07/31/2026
Fidelity Extended Market Index 0.35 12,307 +0.0 07/31/2026
Fidelity Series Total Market Index 0.07 2,449 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?